One candidate is selected each year for the PGY2 Infectious Diseases
Pharmacy Residency at Beth Israel Deaconess Medical Center. The program
begins annually on July 1.
Qualifications for participation in the PGY2 Infectious Diseases Pharmacy
Residency Program are in accordance with criteria set forth by the American
Society of Health System Pharmacists (ASHP).
Graduate of an ASHP Accredited PGY1 Pharmacy training degree program
Graduate of an Accreditation Council for Pharmacy Education
(ACPE)-accredited Doctor of Pharmacy degree program.
Residents must be licensed or eligible for licensure in order to be
licensed in MA within 90 days of the commencement of the residency.
Residents must be authorized to work in the United States on a
full-time basis. Work authorization sponsorship for this position is
Residents shall participate in and obey the rules of the
American Society of Health-System Pharmacists (ASHP) Resident
Your application and all supporting documentation must be received by
January 4th, 2018 of the year you wish to begin the program.
Application templates are available electronically using the Pharmacy
Online Residency Centralized Application (PhORCAS). All applicants must provide the following:
Letter of Interest, including a statement of professional goals and
reasons for pursuing a PGY2 Infectious Diseases Pharmacy Residency
Three Letters of Recommendation
Official Pharmacy School Transcript
Submission of Application Materials
Applications to the BIDMC PGY2 Infectious Diseases Residency program are to
be submitted electronically using the Pharmacy Online Residency Centralized
Applicants considered for an appointment will be invited to visit BIDMC for
a personal interview with the program director and selected faculty. An
interview can be arranged only when your application file is complete.
Completed application packets will be reviewed by select members of the
Residency Advisory Committee (RAC) to determine candidates that most
closely match the BIDMC program goals and opportunities.
Selected candidates will be invited to an onsite interview with members
of the Infectious Diseases Pharmacy Practice Council, the Antimicrobial
Stewardship Medical Director and Attendings as well as Pharmacy
Management. The interview will include a short (15 minute) patient
vignette presentation to the group.
Following the interview process, residency candidates will be ranked
based upon the collaborative input with regard the interviews and
qualifications of the candidate.
A rank list will be submitted to the Resident Matching Program.
Acknowledgment of Residency Match
Residents matched to the BIDMC Residency program will receive an acceptance
letter acknowledging the match and delineating the general terms and
conditions of the residency. Acknowledgment in writing by the resident will
constitute acceptance of the match and agreement to fulfill the duties of
the residency position for the upcoming year.
Pharmacy Licensure Verification
Participation in the BIDMC PGY2 Infectious Diseases Residency Program is
contingent on securing and maintaining a license without restriction in the
State of Massachusetts. It is the expectation that the resident will
complete these licensure requirements within 90 days of the commencement of
The resident will provide the Residency Program Director confirmation that:
He/she has already taken or is scheduled to take the NAPLEX and the
Multistate Pharmacy Jurisprudence Examination (MPJE), or
He/she will take the MPJE upon successful transfer of NAPLEX scores
from another state, or
He/she has already has a valid MA pharmacy license.
Upon notification of successful completion of the NAPLEX and/or MPJE
the resident will provide documentation of licensure to the Residency
Failure to attain licensure is grounds for dismissal from the residency
program. Residents should contact the Residency Program Director should
any issue arise with licensure.